These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 26978507

  • 1. [Meige's syndrome or segmental craniocervical dystonia: terminology, history and contemporary view].
    Zalyalova ZA.
    Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(12):133-136. PubMed ID: 26978507
    [Abstract] [Full Text] [Related]

  • 2. Essential blepharospasm and related dystonias.
    Jordan DR, Patrinely JR, Anderson RL, Thiese SM.
    Surv Ophthalmol; 1989; 34(2):123-32. PubMed ID: 2686056
    [Abstract] [Full Text] [Related]

  • 3. Effects of onabotulinum toxin type A injections in patients with Meige's syndrome.
    Duarte A, Coutinho L, Germiniani FMB, Teive HAG.
    Arq Neuropsiquiatr; 2024 Apr; 82(4):1-7. PubMed ID: 38641339
    [Abstract] [Full Text] [Related]

  • 4. Five-year experience in the treatment of focal movement disorders with low-dose Dysport botulinum toxin.
    Van den Bergh P, Francart J, Mourin S, Kollmann P, Laterre EC.
    Muscle Nerve; 1995 Jul; 18(7):720-9. PubMed ID: 7783762
    [Abstract] [Full Text] [Related]

  • 5. The role of the injection botulinum toxin A in cases of blepharospasm syndrome, hemifacial spasm and Meige's syndrome.
    Bastola P, Chaudhary M, Agrawal JP, Shah DN.
    Kathmandu Univ Med J (KUMJ); 2010 Jul; 8(31):305-10. PubMed ID: 22610735
    [Abstract] [Full Text] [Related]

  • 6. Botulinum toxin in Meige's syndrome: A video-based case series.
    Pandey S, Sharma S.
    Neurol India; 2018 Jul; 66(1):71-76. PubMed ID: 29322963
    [Abstract] [Full Text] [Related]

  • 7. Inability to close eyelids as a feature of palpebral dystonia.
    Krack P, Porschke H, de Decker W, Deuschl G.
    Mov Disord; 1997 Mar; 12(2):251-2. PubMed ID: 9087989
    [No Abstract] [Full Text] [Related]

  • 8. Current status of dystonias including Meige's syndrome.
    Behari M.
    Neurol India; 2018 Mar; 66(1):36-37. PubMed ID: 29322952
    [No Abstract] [Full Text] [Related]

  • 9. Meige's syndrome.
    Verma RK, Gupta BK, Kochar SK, Poonia A, Kochar DK.
    J Assoc Physicians India; 1993 Mar; 41(3):173-4. PubMed ID: 8226604
    [Abstract] [Full Text] [Related]

  • 10. Meige's syndrome: History, epidemiology, clinical features, pathogenesis and treatment.
    Pandey S, Sharma S.
    J Neurol Sci; 2017 Jan 15; 372():162-170. PubMed ID: 28017205
    [Abstract] [Full Text] [Related]

  • 11. Altered functional connectivity in blepharospasm/orofacial dystonia.
    Jochim A, Li Y, Gora-Stahlberg G, Mantel T, Berndt M, Castrop F, Dresel C, Haslinger B.
    Brain Behav; 2018 Jan 15; 8(1):e00894. PubMed ID: 29568690
    [Abstract] [Full Text] [Related]

  • 12. Meige syndrome: what's in a name?
    LeDoux MS.
    Parkinsonism Relat Disord; 2009 Aug 15; 15(7):483-9. PubMed ID: 19457699
    [Abstract] [Full Text] [Related]

  • 13. Treatment of blepharospasm and Meige's syndrome with abo- and onabotulinumtoxinA: long-term safety and efficacy in daily clinical practice.
    Jochim A, Meindl T, Huber C, Mantel T, Zwirner S, Castrop F, Haslinger B.
    J Neurol; 2020 Jan 15; 267(1):267-275. PubMed ID: 31630241
    [Abstract] [Full Text] [Related]

  • 14. Meige's syndrome: A cranial dystonia treated with bilateral pallidal deep brain stimulation.
    Markaki E, Kefalopoulou Z, Georgiopoulos M, Paschali A, Constantoyannis C.
    Clin Neurol Neurosurg; 2010 May 15; 112(4):344-6. PubMed ID: 20061080
    [Abstract] [Full Text] [Related]

  • 15. Facial muscle spasms: an Australian study.
    Kowal L, Davies R, Kiely PM.
    Aust N Z J Ophthalmol; 1998 May 15; 26(2):123-8. PubMed ID: 9630292
    [Abstract] [Full Text] [Related]

  • 16. Use of botulinum toxin in Meige's disease.
    Maurri S, Brogelli S, Alfieri G, Barontini F.
    Riv Neurol; 1988 May 15; 58(6):245-8. PubMed ID: 3247565
    [Abstract] [Full Text] [Related]

  • 17. [Blepharospasm and Meige's syndrome--a contribution to it's pathogenesis].
    Domzał TM, Zaleska B.
    Pol Merkur Lekarski; 2001 Feb 15; 10(56):98-100. PubMed ID: 11320588
    [Abstract] [Full Text] [Related]

  • 18. Levetiracetam in Meige's syndrome.
    Yardimci N, Karatas M, Kilinc M, Benli S.
    Acta Neurol Scand; 2006 Jul 15; 114(1):63-6. PubMed ID: 16774630
    [Abstract] [Full Text] [Related]

  • 19. [Botulinum toxin A: experience in the treatment of 115 patients].
    Andrade LA, Borges V, Ferraz HB, Azevedo-Silva SM.
    Arq Neuropsiquiatr; 1997 Sep 15; 55(3B):553-7. PubMed ID: 9629404
    [Abstract] [Full Text] [Related]

  • 20. [Dystonia as the cause of pharyngolaryngeal motility disorders].
    Zwirner P, Dressler D.
    HNO; 1995 Aug 15; 43(8):498-501. PubMed ID: 7558908
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.